`AO 120 (Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`DELAWARE
`filed in the U.S. District Court
`on the following
`! Trademarks or ! Patents.
`( ! the patent action involves 35 U.S.C. § 292.):
`4
`
`DOCKET NO.
`
`DATE FILED
`12/6/2013
`
`U.S. DISTRICT COURT
`
`PLAINTIFF
`Reckitt Benckiser Pharmaceuticals, Inc., RB
`Pharmaceuticals Limited and MonoSol RX, LLC
`
`DELAWARE
`
`DEFENDANT
`Alvogen Pine Brook, Inc. and Alvogen Group, Inc.
`
`PATENT OR
`TRADEMARK NO.
`8,475,832
`
`DATE OF PATENT
`OR TRADEMARK
`7/2/2013
`
`HOLDER OF PATENT OR TRADEMARK
`
`RB Pharmaceuticals Limited
`
`8,017,150
`
`9/13/2011
`
`MonoSol RX, LLC
`
`1 2 3 4 5
`
`DATE INCLUDED
`
`PATENT OR
`TRADEMARK NO.
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`! Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`! Answer
`
`! Cross Bill
`
`! Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`1 2 3 4 5
`
`In the above—entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`CLERK
`
`(BY) DEPUTY CLERK
`
`DATE
`
`Copy 1—Upon initiation of action, mail this copy to Director Copy 3—Upon termination of action, mail this copy to Director
`Copy 2—Upon filing document adding patent(s), mail this copy to Director Copy 4—Case file copy